Bekele Nigatu Addisu, Hirbu Jarsso Tadesse
Department of Pharmacy, College of Medical and Health Sciences, Dilla University, Dilla, Ethiopia.
Department of Internal Medicine, College of Medical and Health Sciences, Dilla University, Dilla, Ethiopia.
Infect Drug Resist. 2020 Jun 12;13:1743-1750. doi: 10.2147/IDR.S247587. eCollection 2020.
To assess antimicrobial use-related problems and associated factors among patients admitted to medical wards of Dilla University Referral Hospital.
A hospital-based prospective observational study design was employed to assess the antimicrobial use-related problems among adult patients admitted to Dilla University Referral Hospital from 5 March to 4 September 2018. The antimicrobial therapy was reviewed to assure compliance with the recommendations of the national guidelines or evidence-based international clinical guidelines and drug therapy problem was identified. The logistic regression model was fit to determine the association between the different factors and the occurrence of drug therapy problems. Odds ratio was used to show a comparison of factors contributing to drug therapy problems. Statistical significance was considered at p-value <0.05.
In this follow-up to 229 participants, the prevalence of antimicrobial therapy-related problem was 70.74%. "Noncompliance to therapy" was the most frequent DTP experienced by 68 (29.69%) of the patients followed by "needs additional drug therapy" seen among 31 (13.54%) patients. "Adverse drug reaction" was the least and experienced by 7 (3.06%) patients. Others include: dosage too low among 22 (9.61%), dose too high among 17 (8.30%), unnecessarily prescribed antimicrobials among 17 (7.42%) and ineffective antimicrobials among 8 (3.49%) patients. Compared with those who used less than four drugs, the use of four to six (AOR: 4.024) and seven and above (AOR: 13.516) drugs were determinants for antimicrobial use problems. Additionally, infectious cases not addressed by the national guideline (AOR: 3.328) and the unavailability of appropriate lab values results within 48 hours of hospital admission (AOR: 1.285) were determinants for antimicrobial use problems.
Antimicrobial use problem was prevalent with 0.94-problems-per-patient. Polypharmacy, coverage of national guidelines and availing laboratory values within 48 hours of hospital admission were independent determinants of antimicrobial use problems.
评估迪拉大学转诊医院内科病房住院患者的抗菌药物使用相关问题及相关因素。
采用基于医院的前瞻性观察性研究设计,对2018年3月5日至9月4日入住迪拉大学转诊医院的成年患者的抗菌药物使用相关问题进行评估。对抗菌治疗进行审查,以确保符合国家指南或循证国际临床指南的建议,并确定药物治疗问题。采用逻辑回归模型确定不同因素与药物治疗问题发生之间的关联。比值比用于显示导致药物治疗问题的因素的比较。p值<0.05时具有统计学意义。
在对229名参与者的随访中,抗菌治疗相关问题的患病率为70.74%。“治疗不依从”是最常见的药物治疗问题,68名(29.69%)患者出现该问题,其次是31名(13.54%)患者出现“需要额外药物治疗”。“药物不良反应”最少,7名(3.06%)患者出现该问题。其他问题包括:22名(9.61%)患者剂量过低,17名(8.30%)患者剂量过高,17名(7.42%)患者抗菌药物处方不必要,8名(3.49%)患者抗菌药物无效。与使用少于四种药物的患者相比,使用四至六种(比值比:4.024)和七种及以上(比值比:13.516)药物是抗菌药物使用问题的决定因素。此外,国家指南未涵盖的感染病例(比值比:3.328)以及入院48小时内未获得适当的实验室检查结果(比值比:1.285)是抗菌药物使用问题的决定因素。
抗菌药物使用问题普遍存在,每位患者有0.94个问题。联合用药、国家指南的覆盖范围以及入院48小时内获得实验室检查结果是抗菌药物使用问题的独立决定因素。